Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

96

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

96 results for “L-Arginin”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov32/100

Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women

ClinicalTrials.gov study NCT00001752. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD

ClinicalTrials.gov study NCT01855334. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Study of Effects of L-Arginine in Colitis and Colon Cancer

ClinicalTrials.gov study NCT01091558. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2)

ClinicalTrials.gov study NCT04637906. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Role of L-Arginine Supplementation in the Treatment of Rheumatoid Arthritis

ClinicalTrials.gov study NCT04535427. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Directed Immuno Nutrition by L-arginine for Critically Ill Patients

ClinicalTrials.gov study NCT01038622. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Prevention of Type 2 Diabetes Mellitus by L-Arginine in Patients With Metabolic Syndrome

ClinicalTrials.gov study NCT00917449. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

L-Arginine in Children Having Sickle Cell Disease With Increased Tricuspid Regurgitant Jet Velocity

ClinicalTrials.gov study NCT05470998. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

L-arginine Therapy on Endothelium-dependent Vasodilation & Mitochondrial Metabolism in MELAS Syndrome

ClinicalTrials.gov study NCT01603446. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Effect of the Amino Acid L-arginine on Perioperative Cardio-vascular Risk in Non-selected Patients

ClinicalTrials.gov study NCT01413815. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

L-arginine and Asymmetric Dimethylarginine (ADMA) and Lifestyle Protocols

ClinicalTrials.gov study NCT04406402. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

L-arginine Treatment in Mild Hypertension

ClinicalTrials.gov study NCT02894723. IPD Sharing: UNDECIDED. Countries: 1. Publications: 20.

restrictedIPD-UNDECIDEDFeb 2026View details →
dryad32/100

Data from: PMMA bone cement with L-Arginine/nano fish bone nanocomplex to generate apatite formation

Open the record for dataset details and reuse information.

publicAug 2023View details →
zenodo28/100

Figure 4 from: Nugroho A, Tamtomo DG, Indarto D, Cilmiaty R, Soetrisno (2024) The effect of L-Arginine from Giant Snake Head fish (Channa micropeltes) on neuroinflammation and neuron damage in traumatic brain injury in rats. Pharmacia 71: 1-9. https://doi.org/10.3897/pharmacia.71.e111239

Figure 4 Immunohistochemical staining of Caspase-3 400× microscope magnification. Picture of caspase 3 expression in the cerebral cortex area shows a picture of caspase 3 expression in the cytoplasm of neuron cells (yellow arrow). A. The normal control group showed a score of 0; B. The negative control group shows a score of 4; C. Group A shows a score of 3; D. Group B shows a score of 2; E. Group C shows a score of 1.

opencc-by-4.0Feb 2024View details →
zenodo28/100

Figure 5 from: Nugroho A, Tamtomo DG, Indarto D, Cilmiaty R, Soetrisno (2024) The effect of L-Arginine from Giant Snake Head fish (Channa micropeltes) on neuroinflammation and neuron damage in traumatic brain injury in rats. Pharmacia 71: 1-9. https://doi.org/10.3897/pharmacia.71.e111239

Figure 5 Histopathological picture of brain tissue damage with HE staining, 400× microscope magnification. Description: Histopathological picture of the cerebral cortex area shows degeneration of neuron cells (yellow arrows). A. The normal control group shows a score of 0; B. The negative control group shows a score of 2; C. Group A shows a score of 2; D. Group B shows a score of 1; E. Group C shows a score of 1.

opencc-by-4.0Feb 2024View details →
zenodo28/100

Figure 2 from: Nugroho A, Tamtomo DG, Indarto D, Cilmiaty R, Soetrisno (2024) The effect of L-Arginine from Giant Snake Head fish (Channa micropeltes) on neuroinflammation and neuron damage in traumatic brain injury in rats. Pharmacia 71: 1-9. https://doi.org/10.3897/pharmacia.71.e111239

Figure 2 TLR4 immunohistochemical staining with a microscope magnification of 400×. Description: TLR4 expression in the cerebral cortex area shows TLR4 expression in astrocytes (yellow arrows). A. Control group normally expressed 5%; B. Negative control group expressed 20%; C. Group A expressed 15%; D. Group B expressed 15%; E. Group C expressed 10%.

opencc-by-4.0Feb 2024View details →
zenodo28/100

Figure 3 from: Nugroho A, Tamtomo DG, Indarto D, Cilmiaty R, Soetrisno (2024) The effect of L-Arginine from Giant Snake Head fish (Channa micropeltes) on neuroinflammation and neuron damage in traumatic brain injury in rats. Pharmacia 71: 1-9. https://doi.org/10.3897/pharmacia.71.e111239

Figure 3 TNF-α immunohistochemical staining with a microscope magnification of 400×. TNF-α expression in the cerebral cortex area shows TNF-α expression in astrocytes (yellow arrows). A. Control group normally expressed 5%; B. Negative control group expressed 15%; C. Group A was depressed 10%; D. Group B expressed 10%; E. Group C expressed 5%.

opencc-by-4.0Feb 2024View details →
dryad28/100

Effectiveness of acute L-arginine supplementation on physical performance in strength training: a systematic review and meta-analysis

<p><span>The oral administration of L-arginine has been related to improved physical performance due to a likely reduction in muscle fatigue, resulting from the vasodilator effect of nitric oxide on skeletal muscle. However, there is no precise and quantitative analysis of the information in the literature. </span>Objective:<span> The main objective was to assess the effectiveness of L-arginine supplementation on physical performance in strength training with a systematic review and meta-analysis. Methods: Systematic review and meta-analysis, the PRISMA® (Preferred Reporting Items for Systematic Reviews and Meta-Analysis), PICOS statement and methodology guidelines, the quality of evidence by Classification of Assessment, Development and Assessment Recommendations (GRADE), Multiple Systematic Review Tool Assessment (AMSTAR2)</span><span>, and to assess the risk of bias of randomized clinical trials, the RoB 2.0 tool (Risk of Bias - Cochrane risk of bias tool revised for randomized trials)</span><span>. </span><span>The inclusion process established articles with well-designed human experiments that included only L-arginine supplementation testing the effects of L-arginine supplementation on sports performance related to strength training; identical experimental conditions in placebo or control group; and publications in the last ten years (until December 31, 2020). Three studies were included that compared L-arginine supplementation with placebo in anaerobic performance tests. </span>Results:<span> There was no significant heterogeneity (p&gt;0.05) in the analysis of the three selected articles and the effects of L-arginine supplementation in muscular endurance; performance had a mean of 0.26 (95% CI = -0.129; 0.649; p = 0.190), peak torque with a mean of -0.002 (95% CI = -0.531; 0.527; p = 0. 99) of the third series of exercises and, furthermore, when comparing the integrated effect (resistance rate with the peak torque) there was no difference with a mean of 0.168 (95% CI = -0.145; 0.481; p = 0.292). </span></p> <p>Conclusions:<span> Acute L-arginine supplementation provides no ergogenic effect on strength training performance.</span></p>

opencc-zeroOct 2021View details →
ClinicalTrials.gov28/100

Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma

ClinicalTrials.gov study NCT00280683. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Supplementation of L-arginine in Patients With Non-resectable Brain Metastases

ClinicalTrials.gov study NCT02844387. IPD Sharing: YES. Countries: 0. Publications: 5.

controlledIPD-YESFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record